ADAM GAZZALEY

Adam Gazzaley is a distinguished Venture Partner at Jazz Venture Partners, a leading venture capital firm committed to investing in companies that leverage neuroscience and technology to enhance human health and performance. With a profound background as a neuroscientist and academic, Adam brings unparalleled scientific rigor and insight to the firm's investment strategy.

At Jazz Venture Partners, Adam plays a crucial role in identifying, evaluating, and supporting early-stage companies poised to revolutionize brain health, mental wellness, and human potential. His investment focus areas are deeply rooted in his expertise, encompassing digital therapeutics, neurotechnology, cognitive enhancement, personalized medicine, and solutions for improving mental and physical performance. He helps guide the firm's portfolio towards ventures that offer scientifically validated approaches to complex challenges in health and well-being.

Beyond his contributions to venture capital, Adam Gazzaley is a highly respected figure in academia. He is a Professor of Neurology, Physiology, and Psychiatry at the University of California, San Francisco (UCSF). Furthermore, he is the founder and Executive Director of Neuroscape, a translational neuroscience center at UCSF dedicated to developing and validating advanced technologies for brain assessment and optimization. His pioneering research explores how technology, including video games and virtual reality, can be harnessed to improve cognitive abilities, attention, and memory across the lifespan. He is also the co-author of "The Distracted Mind: Ancient Brains in a High-Tech World."

Adam's unique position at the nexus of cutting-edge neuroscience research and venture capital allows him to bridge the gap between scientific discovery and market-ready solutions. He provides invaluable guidance to Jazz Venture Partners' portfolio companies, ensuring their innovations are grounded in robust scientific principles and have the potential for significant real-world impact. While specific individual investments for a Venture Partner are often less publicized, his influence is evident across Jazz's portfolio, which includes companies developing digital treatments for neurological and psychiatric conditions, advanced brain training platforms, and tools for optimizing human performance. His vision is to empower individuals to achieve their full cognitive and emotional potential through scientifically informed technological advancements.